Table 4b.
Pons plasmalogen mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD (control) | Patient | Mean (control) | SD (control) | |
|
|
||||||
| EtnGpl | 7044 | 5407 | 590* | 26.5% | 29.4% | 0.9%* |
| PlsEtn | 19492 | 13021 | 1959* | 73.5% | 70.6% | 0.9%* |
| ChoGpl | 16526 | 11640 | 2705 | 87.8% | 87.2% | 3.7% |
| PlsCho | 2293 | 1650 | 163* | 12.2% | 12.8% | 3.7% |
| n = 1 | n = 2 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
indicates significance between patient and control group, 2 SD from control mean.